TIMMER WOLFGANG ET AL: 'The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-alpha ex vivo.', JOURNAL OF CLINICAL PHARMACOLOGY, vol. 42, no. 3, March 2002 (2002-03-01), pages 297 - 303, XP009017956, ISSN: 0091-2700